| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q2L6
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
| GO:0007165 | signal transduction | 2 | 2 |
| GO:0007264 | small GTPase mediated signal transduction | 4 | 2 |
| GO:0007265 | Ras protein signal transduction | 5 | 2 |
| GO:0008152 | metabolic process | 1 | 2 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0016567 | protein ubiquitination | 7 | 2 |
| GO:0019538 | protein metabolic process | 3 | 2 |
| GO:0032446 | protein modification by small protein conjugation | 6 | 2 |
| GO:0035556 | intracellular signal transduction | 3 | 2 |
| GO:0036211 | protein modification process | 4 | 2 |
| GO:0043170 | macromolecule metabolic process | 3 | 2 |
| GO:0043412 | macromolecule modification | 4 | 2 |
| GO:0044238 | primary metabolic process | 2 | 2 |
| GO:0050789 | regulation of biological process | 2 | 2 |
| GO:0050794 | regulation of cellular process | 3 | 2 |
| GO:0065007 | biological regulation | 1 | 2 |
| GO:0070647 | protein modification by small protein conjugation or removal | 5 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 2 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 3 |
| GO:0004842 | ubiquitin-protein transferase activity | 4 | 2 |
| GO:0005488 | binding | 1 | 12 |
| GO:0008270 | zinc ion binding | 6 | 12 |
| GO:0016740 | transferase activity | 2 | 2 |
| GO:0019787 | ubiquitin-like protein transferase activity | 3 | 2 |
| GO:0043167 | ion binding | 2 | 12 |
| GO:0043169 | cation binding | 3 | 12 |
| GO:0046872 | metal ion binding | 4 | 12 |
| GO:0046914 | transition metal ion binding | 5 | 12 |
| GO:0061630 | ubiquitin protein ligase activity | 5 | 2 |
| GO:0061659 | ubiquitin-like protein ligase activity | 4 | 2 |
| GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
| GO:0016787 | hydrolase activity | 2 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 282 | 286 | PF00656 | 0.545 |
| CLV_C14_Caspase3-7 | 67 | 71 | PF00656 | 0.628 |
| CLV_NRD_NRD_1 | 127 | 129 | PF00675 | 0.552 |
| CLV_NRD_NRD_1 | 352 | 354 | PF00675 | 0.583 |
| CLV_NRD_NRD_1 | 426 | 428 | PF00675 | 0.567 |
| CLV_NRD_NRD_1 | 464 | 466 | PF00675 | 0.699 |
| CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.552 |
| CLV_PCSK_KEX2_1 | 287 | 289 | PF00082 | 0.504 |
| CLV_PCSK_KEX2_1 | 351 | 353 | PF00082 | 0.590 |
| CLV_PCSK_KEX2_1 | 426 | 428 | PF00082 | 0.599 |
| CLV_PCSK_KEX2_1 | 464 | 466 | PF00082 | 0.721 |
| CLV_PCSK_PC1ET2_1 | 287 | 289 | PF00082 | 0.556 |
| CLV_PCSK_PC1ET2_1 | 351 | 353 | PF00082 | 0.578 |
| CLV_PCSK_SKI1_1 | 267 | 271 | PF00082 | 0.600 |
| CLV_PCSK_SKI1_1 | 287 | 291 | PF00082 | 0.260 |
| CLV_PCSK_SKI1_1 | 363 | 367 | PF00082 | 0.554 |
| CLV_PCSK_SKI1_1 | 409 | 413 | PF00082 | 0.571 |
| CLV_PCSK_SKI1_1 | 439 | 443 | PF00082 | 0.714 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.532 |
| DEG_SPOP_SBC_1 | 49 | 53 | PF00917 | 0.550 |
| DOC_CYCLIN_yClb5_NLxxxL_5 | 363 | 369 | PF00134 | 0.543 |
| DOC_MAPK_MEF2A_6 | 153 | 161 | PF00069 | 0.514 |
| DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.621 |
| DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.461 |
| DOC_USP7_MATH_1 | 340 | 344 | PF00917 | 0.606 |
| DOC_USP7_MATH_1 | 389 | 393 | PF00917 | 0.579 |
| DOC_USP7_UBL2_3 | 255 | 259 | PF12436 | 0.545 |
| DOC_USP7_UBL2_3 | 264 | 268 | PF12436 | 0.502 |
| DOC_WW_Pin1_4 | 247 | 252 | PF00397 | 0.704 |
| DOC_WW_Pin1_4 | 98 | 103 | PF00397 | 0.569 |
| LIG_14-3-3_CanoR_1 | 352 | 362 | PF00244 | 0.506 |
| LIG_14-3-3_CanoR_1 | 403 | 411 | PF00244 | 0.475 |
| LIG_14-3-3_CanoR_1 | 50 | 55 | PF00244 | 0.567 |
| LIG_Actin_WH2_2 | 376 | 393 | PF00022 | 0.504 |
| LIG_AP2alpha_2 | 156 | 158 | PF02296 | 0.464 |
| LIG_EH1_1 | 205 | 213 | PF00400 | 0.624 |
| LIG_FHA_1 | 114 | 120 | PF00498 | 0.584 |
| LIG_FHA_1 | 191 | 197 | PF00498 | 0.453 |
| LIG_FHA_1 | 353 | 359 | PF00498 | 0.597 |
| LIG_FHA_1 | 374 | 380 | PF00498 | 0.542 |
| LIG_FHA_1 | 385 | 391 | PF00498 | 0.476 |
| LIG_FHA_2 | 310 | 316 | PF00498 | 0.741 |
| LIG_FHA_2 | 319 | 325 | PF00498 | 0.630 |
| LIG_FHA_2 | 334 | 340 | PF00498 | 0.600 |
| LIG_FHA_2 | 369 | 375 | PF00498 | 0.573 |
| LIG_FHA_2 | 412 | 418 | PF00498 | 0.449 |
| LIG_FHA_2 | 65 | 71 | PF00498 | 0.654 |
| LIG_LIR_Apic_2 | 76 | 81 | PF02991 | 0.530 |
| LIG_LIR_Gen_1 | 156 | 166 | PF02991 | 0.444 |
| LIG_LIR_Gen_1 | 169 | 176 | PF02991 | 0.444 |
| LIG_LIR_Gen_1 | 218 | 225 | PF02991 | 0.690 |
| LIG_LIR_Gen_1 | 330 | 338 | PF02991 | 0.630 |
| LIG_LIR_Nem_3 | 156 | 161 | PF02991 | 0.444 |
| LIG_LIR_Nem_3 | 218 | 224 | PF02991 | 0.686 |
| LIG_LIR_Nem_3 | 330 | 334 | PF02991 | 0.612 |
| LIG_LIR_Nem_3 | 336 | 341 | PF02991 | 0.583 |
| LIG_LIR_Nem_3 | 76 | 80 | PF02991 | 0.523 |
| LIG_PTAP_UEV_1 | 139 | 144 | PF05743 | 0.360 |
| LIG_SH2_CRK | 276 | 280 | PF00017 | 0.572 |
| LIG_SH2_STAP1 | 265 | 269 | PF00017 | 0.530 |
| LIG_SH2_STAP1 | 276 | 280 | PF00017 | 0.441 |
| LIG_SH2_STAP1 | 291 | 295 | PF00017 | 0.464 |
| LIG_SH2_STAT3 | 135 | 138 | PF00017 | 0.526 |
| LIG_SH2_STAT3 | 291 | 294 | PF00017 | 0.579 |
| LIG_SH2_STAT3 | 97 | 100 | PF00017 | 0.627 |
| LIG_SH2_STAT5 | 165 | 168 | PF00017 | 0.492 |
| LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.573 |
| LIG_SH2_STAT5 | 79 | 82 | PF00017 | 0.499 |
| LIG_SH3_1 | 78 | 84 | PF00018 | 0.591 |
| LIG_SH3_3 | 137 | 143 | PF00018 | 0.361 |
| LIG_SH3_3 | 78 | 84 | PF00018 | 0.591 |
| LIG_SUMO_SIM_anti_2 | 31 | 37 | PF11976 | 0.517 |
| LIG_SUMO_SIM_anti_2 | 438 | 444 | PF11976 | 0.629 |
| LIG_SUMO_SIM_par_1 | 207 | 216 | PF11976 | 0.518 |
| LIG_UBA3_1 | 345 | 351 | PF00899 | 0.500 |
| MOD_CK1_1 | 113 | 119 | PF00069 | 0.644 |
| MOD_CK1_1 | 215 | 221 | PF00069 | 0.556 |
| MOD_CK1_1 | 385 | 391 | PF00069 | 0.556 |
| MOD_CK1_1 | 446 | 452 | PF00069 | 0.685 |
| MOD_CK2_1 | 318 | 324 | PF00069 | 0.588 |
| MOD_CK2_1 | 333 | 339 | PF00069 | 0.604 |
| MOD_CK2_1 | 368 | 374 | PF00069 | 0.521 |
| MOD_CK2_1 | 404 | 410 | PF00069 | 0.497 |
| MOD_Cter_Amidation | 462 | 465 | PF01082 | 0.667 |
| MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.557 |
| MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.502 |
| MOD_GlcNHglycan | 261 | 264 | PF01048 | 0.651 |
| MOD_GlcNHglycan | 300 | 303 | PF01048 | 0.685 |
| MOD_GlcNHglycan | 445 | 448 | PF01048 | 0.668 |
| MOD_GSK3_1 | 102 | 109 | PF00069 | 0.503 |
| MOD_GSK3_1 | 211 | 218 | PF00069 | 0.622 |
| MOD_GSK3_1 | 309 | 316 | PF00069 | 0.718 |
| MOD_GSK3_1 | 385 | 392 | PF00069 | 0.459 |
| MOD_GSK3_1 | 92 | 99 | PF00069 | 0.551 |
| MOD_NEK2_1 | 118 | 123 | PF00069 | 0.545 |
| MOD_NEK2_1 | 211 | 216 | PF00069 | 0.564 |
| MOD_NEK2_1 | 269 | 274 | PF00069 | 0.575 |
| MOD_NEK2_1 | 290 | 295 | PF00069 | 0.557 |
| MOD_NEK2_1 | 402 | 407 | PF00069 | 0.478 |
| MOD_NEK2_1 | 411 | 416 | PF00069 | 0.398 |
| MOD_NEK2_1 | 90 | 95 | PF00069 | 0.577 |
| MOD_OFUCOSY | 117 | 123 | PF10250 | 0.474 |
| MOD_PIKK_1 | 110 | 116 | PF00454 | 0.331 |
| MOD_PIKK_1 | 190 | 196 | PF00454 | 0.453 |
| MOD_PIKK_1 | 290 | 296 | PF00454 | 0.588 |
| MOD_PIKK_1 | 421 | 427 | PF00454 | 0.585 |
| MOD_PIKK_1 | 96 | 102 | PF00454 | 0.623 |
| MOD_PKA_1 | 267 | 273 | PF00069 | 0.625 |
| MOD_PKA_1 | 352 | 358 | PF00069 | 0.570 |
| MOD_PKA_2 | 352 | 358 | PF00069 | 0.517 |
| MOD_PKA_2 | 402 | 408 | PF00069 | 0.497 |
| MOD_PKA_2 | 463 | 469 | PF00069 | 0.773 |
| MOD_PKA_2 | 49 | 55 | PF00069 | 0.596 |
| MOD_Plk_1 | 374 | 380 | PF00069 | 0.504 |
| MOD_Plk_1 | 90 | 96 | PF00069 | 0.591 |
| MOD_Plk_4 | 217 | 223 | PF00069 | 0.682 |
| MOD_Plk_4 | 31 | 37 | PF00069 | 0.487 |
| MOD_Plk_4 | 340 | 346 | PF00069 | 0.551 |
| MOD_Plk_4 | 50 | 56 | PF00069 | 0.599 |
| MOD_Plk_4 | 73 | 79 | PF00069 | 0.656 |
| MOD_ProDKin_1 | 247 | 253 | PF00069 | 0.700 |
| MOD_ProDKin_1 | 98 | 104 | PF00069 | 0.563 |
| MOD_SUMO_for_1 | 146 | 149 | PF00179 | 0.506 |
| MOD_SUMO_for_1 | 280 | 283 | PF00179 | 0.542 |
| MOD_SUMO_for_1 | 365 | 368 | PF00179 | 0.509 |
| MOD_SUMO_rev_2 | 252 | 261 | PF00179 | 0.637 |
| MOD_SUMO_rev_2 | 262 | 270 | PF00179 | 0.567 |
| MOD_SUMO_rev_2 | 282 | 289 | PF00179 | 0.245 |
| MOD_SUMO_rev_2 | 405 | 414 | PF00179 | 0.524 |
| TRG_DiLeu_BaEn_4 | 374 | 380 | PF01217 | 0.587 |
| TRG_ENDOCYTIC_2 | 171 | 174 | PF00928 | 0.514 |
| TRG_ENDOCYTIC_2 | 276 | 279 | PF00928 | 0.563 |
| TRG_ENDOCYTIC_2 | 331 | 334 | PF00928 | 0.602 |
| TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.518 |
| TRG_ER_diArg_1 | 127 | 129 | PF00400 | 0.552 |
| TRG_ER_diArg_1 | 426 | 428 | PF00400 | 0.570 |
| TRG_NES_CRM1_1 | 27 | 41 | PF08389 | 0.486 |
| TRG_Pf-PMV_PEXEL_1 | 288 | 292 | PF00026 | 0.567 |
| TRG_Pf-PMV_PEXEL_1 | 409 | 413 | PF00026 | 0.538 |
| TRG_Pf-PMV_PEXEL_1 | 426 | 431 | PF00026 | 0.470 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PAV0 | Leptomonas seymouri | 68% | 79% |
| A0A0S4ILW6 | Bodo saltans | 32% | 83% |
| A0A1X0PAX0 | Trypanosomatidae | 35% | 94% |
| A0A3Q8IEL0 | Leishmania donovani | 92% | 100% |
| A0A422NNH1 | Trypanosoma rangeli | 36% | 96% |
| A4HB46 | Leishmania braziliensis | 79% | 100% |
| A4IA95 | Leishmania infantum | 92% | 81% |
| C9ZLZ9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 96% |
| E5KGE0 | Arabidopsis thaliana | 28% | 98% |
| E9B5B7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
| O13747 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 87% |
| Q7Z569 | Homo sapiens | 23% | 81% |
| Q95QN6 | Caenorhabditis elegans | 24% | 81% |
| Q99MP8 | Mus musculus | 23% | 81% |
| V5DLZ1 | Trypanosoma cruzi | 35% | 94% |